Moribund Bionovo flogs stock before exiting Nasdaq
This article was originally published in Scrip
Executive Summary
Emeryville, California-based Bionovo may have gasped its last breath this week with a common stock offering and sale of warrants that is expected to generate less than a million dollar four days after the pharmaceutical firm announced that it will cut management salaries and reduce its workforce by 90 percent.